Clinical Trial Update: Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients [NA]

View source ↗

Summary

Clinical trial update evaluating safety and efficacy of lean body weight-based IV heparin dosing in obese and morbidly obese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina
• Atrial Fibrillation
• Morbid Obesity
• Obesity
• Venous Thromboembolism

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: Nazareth Hospital | Conditions: Obesity, Morbid Obesity | NA | Status: UNKNOWN